Thomas McCauley insider trades

Open-market stock purchases and sales by Thomas McCauley, Chief Scientific Officer at Stoke Therapeutics, Inc, from SEC Form 4 filings since Mar 9, 2022.

Recent trades

DateStockTradeValue
Jul 15, 2026STOK Stoke Therapeutics, IncBought (not open market)—

Companies traded

  • STOK Stoke Therapeutics, Inc: other filings, last Jul 15, 2026
  • OMGA Omega Therapeutics, Inc: other filings, last Feb 7, 2024

Get free alerts when Thomas McCauley files a new trade →